| MR编号 | SE/H/2027/002 |
|---|
| 药品名称 | Vimetso |
|---|
| 活性成分 | - Metformin hydrochloride 1000.0 mg
- vildagliptin 50.0 mg
|
|---|
| 剂型 | Film-coated tablet |
|---|
| 上市许可持有人 | Krka d.d. Novo Mesto, Slovenia |
|---|
| 参考成员国 - 产品名称 | Sweden (SE) |
|---|
| 互认成员国 - 产品名称 | - Latvia (LV)
Vimetso 50 mg/1000 mg apvalkotās tabletes - Lithuania (LT)
Vimetso 50 mg/1000 mg plėvele dengtos tabletės - Estonia (EE)
- Hungary (HU)
- Bulgaria (BG)
Glypvicombi - Cyprus (CY)
Glypvicombi 50mg/1000mg FCT - Czechia (CZ)
Glypvicombi 50mg/1000mg potahované tablety - Slovakia (SK)
Vimetso 50 mg/1000 mg filmom obalené tablety - Slovenia (SI)
- Malta (MT)
Vimetso 50 mg/1000 mg film-coated tablets - Greece (GR)
- Croatia (HR)
Vimetso 50 mg/1000 mg filmom obložene tablete - Poland (PL)
Vimetsi
|
|---|
| 许可日期 | 2021/06/16 |
|---|
| 最近更新日期 | 2024/12/19 |
|---|
| 药物ATC编码 | - A10BD08 metformin and vildagliptin
|
|---|
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Multiple (Copy) Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|